Neopterin is produced by monocytes and is a useful biomarker of inflammatory responses. We found that neopterin enhances granulopoiesis, but suppresses B-lymphopoiesis triggered by the positive-and negative regulations of cytokines produced by stromal cells in mice. Furthermore, neopterin suppressed the colony formation of mast cell progenitor (CFU-mast) from bone marrow cells in in vitro culture system. In this study, neopterin was also found to regulate the proliferation and differentiation of splenic CFU-mast in vitro as observed in that from bone marrow, which was confirmed in the mouse model of senescent stromal-cell impairment (SCI). In non-SCI mice (=less senescent stage of SCI mice), neopterin also decreased the number of colonies of interleukin-3 (IL-3)-dependent mast-cell progenitor cells (CFU-mast) from unfractionated spleen cells, but not that from the lineage-negative (fractionated) spleen cell population without stromal cells in a semisolid in vitro culture system. In contrast, in a case of SCI mice, the treatment with neopterin did not decrease the number of colonies of IL-3-dependent mast-cell progenitor cells (CFU-mast) from unfractionated spleen cells. These results suggest that, firstly, neopterin decrease the number of colonies of IL-3-dependent CFU-mast by stimulating splenic stromal cells, and secondly, such neopterin function becomes declined during senescence because of an impaired stromalcell function.
Introduction
Neopterin is a metabolite of guanosine triphosphate that is produced in the biopterin synthetic pathway (1) . This metabolite is generated in large amounts by monocytes and macrophages in response to interferon-γ (IFN-γ) (2) . An increased neopterin production is observed following infection by viruses, bacteria and parasites (3) . Because neopterin level in body fluid reflects immune responses in vivo, neopterin is regarded as a sensitive marker of the activation of the cellular immune system in humans as well as a factor for prognosis and its indicator biomarker (3, 4) . However, there is evidence that neopterin is not only a marker of the activity of the immune system, but it also exerts distinct biological effects (3, 4) .
We have recently found that neopterin augments the colony formation of femoral and splenic granulocytemacrophage progenitor cells (CFU-GM) in a semisolid culture system, which is due not to a direct effect of neopterin on hematopoietic stem cells, but rather to an indirect effect of stromal-cell-mediated hematopoietic growth factors, such as granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-6 (IL-6) (5). In contrast to the enhancement of CFU-GM colony formation by neopterin, neopterin suppresses in vitro colony formation of B cell progenitor (CFU-Pre-B) and mast cell progenitor (CFU-mast) obtained from bone marrow by inducing the production of predominantly negative regulators by stromal cells, such as tumor necrosis factor-α (TNF-α), IL-6 and transforming growth factor-β (TGF-β) (6, 7) . These findings indicate that neopterin is biologically active against hematopoiesis during inflammatory processes, which is induced by stimulating the production of cytokines from bone marrow stromal cells.
SAM/P-1, a subline of senescence-accelerated mice (SAM) exhibiting a unique stromal cell impairment after 30 weeks of age, was used because the numbers of splenic cells and splenic hematopoietic progenitor cells start to decrease thereafter (8) (9) (10) (11) . Therefore, stromal cell impairment (SCI) mice, SAM/P-1, are a useful tool for elucidating the possible interaction between neopterin and splenic stromal cells during mast cell development. In this study using a stromal impairment (SCI) mouse, SAM/P-1, we investigated whether neopterin affects the proliferation and differentiation of splenic CFU-mast via stimulating splenic stromal cell as observed in femoral CFU-mast.
Materials and Methods

Mice
A subline of SAM, SAM/P-1 (8) , which is a senescent stromal impairment substrain (SCI mouse), was derived from an AKR/J mouse (Jackson Laboratory, Bar Harbor, ME), and established by Dr. Toshio Takeda, Professor Emeritus of the Chest Disease Research Institute, Kyoto University, Japan. The mice were bred and maintained in an experimental facility at the National Institute of Health Sciences under pathogen-free conditions. SAM/P-1 exhibits stromal cell impairment after 30 -36 weeks of age. In this study, male SAM/P-1 mice designated as non-SCI (8 -12 weeks old) and those designated as SCI mice (30 -36 weeks old) were compared. These ages were selected because the numbers of splenic cells and splenic hematopoietic progenitor cells start to decrease at approximately 30 weeks of age (10, 11) . The study was approved by the Committee for Institutional Animal Care and Use at National Institute of Health Sciences under the Health Guidelines for Animal Care and all experimental procedures were carried out in accordance with the guidelines of the Nihon University Laboratory Animal Research Committee.
Agents and antibodies D-(+)-Neopterin was obtained from Sigma (St. Louis, MO). Neopterin was dissolved in 1N HCl at 1 mg/mL and diluted tenfold with Dulbecco's phosphatebuffered saline (PBS). Hamerlinck reported that the concentration of neopterin is 5.89±1.78 nM in normal human serum (19) . Murr et al. showed that the mean serum neopterin level in patients with serious infection by Streptococcus pyogenes is 152 nM (range, 71-242 nM) (12) . Thus, we used neopterin at concentrations from 40 nM to 40 µM for in vitro experiment (13, 14) . Monoclonal antibodies against mouse Mac-1, TER119, Gr-1, Thy1.2, and B220 were purchased from BD PharMingen (San Diego, CA). Sheep anti-rat IgGcoated immunomagnetic beads (Dynabeads M450 sheep anti-rat IgG) were purchased from Dynal (Great Neck, NY).
Preparation of unfractionated marrow spleen cells
Splenic tissue samples were minced in ice-cold α-minimum essential medium (α-MEM; Life Technology, Grand Island, NY) and gently homogenized in Potter's glass homogenizer to obtain a singlecell suspension.
Isolation of Lineage-negative spleen cells [Lin (-) spleen cells]
The above-mentioned spleen cells were washed with α-MEM once, and cell pellets were suspended in 10 mL of 0.86% NH 4 Cl for 5 min at 4°C for lysis of erythrocytes. The spleen cells were then washed twice with α-MEM and mononuclear cells of the BM were obtained. Lin (-) spleen cells were collected using the above-mentioned antibodies and immunomagnetic beads as described previously (15) . Briefly, Mac-1-, TER119-, Gr-1-, Thy1. 
In vitro colony assays
The method used for the assay of colony formation by colony-forming unit-mast (CFU-mast) cells has been described in detail elsewhere (10, 16) . Briefly, spleen cells were cultured in 35-mm plastic dishes (Falcon, Becton Dickinson, Franklin Lakes, NJ) in 2 mL of semisolid α-MEM containing 0.33% BactoAgar (Difco Laboratories, Detroit MI), 25% horse serum (JRH Bioscience, Lenexa, KS) and 20% STILconditioned medium as a source of interleukin-3 (IL-3) (17) . Quadruplicate culture plates containing equal amounts of CFU-mast cells were incubated at 37°C in a completely humidified atmosphere of 5% CO 2 in air. Aggregates of 50 or more cells were counted as colonies on day 21.
Statistical analyses
All data are presented as mean±SD. Differences among experimental groups were assessed using oneway analysis of variance (ANOVA). The level of statistical significance was accepted at P< 0.05.
Results and Discussion
To determine whether neopterin directly affects the proliferation or differentiation of splenic mast cell progenitors (CFU-mast) as observed in femoral CFUmast, we cultured unfractionated spleen cells from young non-SCI and senescent SCI mice in a soft agar culture medium containing IL-3 and neopterin at various concentrations, and measured the number of colonies formed (Fig. 1) . Figure 1 , left (whole spleen cells) shows the in vitro effect of neopterin on CFUmast in unfractionated BMCs from non-SCI and SCI mice. When neopterin at a graded increase in doses was administered from 40 nM to 40 µM, the number of CFU-mast colonies formed by unfractionated spleen cells derived from non-SCI mice significantly decreased in a dose-dependent manner compared with that from the nontreated non-SCI groups (86.8% for 40nM, 82.9% for 400nM, 60.0% for 4µM; P <0.05 and 33.8% for 40µM; P <0.001). Interestingly, these decreases in the number of CFU-mast colonies were observed to be small for unfractionated spleen cells from SCI mice (90.0% for 40nM, 92.2% for 400nM, 92.9% for 4µM and 73.3% for 40µM). * However, the above suppression of CFU-mast colony formation was not observed when spleen cells from non-SCI were fractionated, and Lin (-) spleen cells were isolated and seeded with various concentration of neopterin (Fig. 1, right) . These data indicate that the inhibition of IL-3-dependent mast cell progenitor proliferation and differentiation of unfractionated spleen cells following neopterin administration is not a direct effect but rather an indirect effect of neopterin, presumably a stromal-cell-mediated effect, which is a same manner in the bone marrow cells.
Chen reported the reduction in the seeding of transplanted hematopoietic stem cell into the spleen of aged mice, which suggested that hematopoietic supportive capacity of the spleen was reduced with aging (18) . Further the age-related decrease of number of various hematopoietic progenitor cells in SAM-P mice is more predominant in the spleen than in the bone marrow (10) . These data suggested that stromal-cell-function is more severely impaired in the spleen than in the bone marrow with aging. In a case of SCI mice, the suppressive effect of neopterin on femoral CFU-mast colony-formation was observed at lower doses of neopterin than 40nM (7), whereas that on splenic CFU-mast colony-formation was observed at a dose of neopterin with 40 µM. These results also appear that stromal-cell-function is more severely impaired in the spleen than in the bone marrow with aging, resulting in that splenic stromal cells of SCI were less-sensitive to neopterin compared with bone marrow stromal cells.
Further studies are required to elucidate the mechanisms underlying neopterin action, but our present findings taken together provide evidence that neopterin is a potent regulatory factor for mast cell development in the spleen via the activation of splenic hematopoietic-microenvironment during inflammatory processes.
